Zacks

  • Home
  • Analyst Bios
  • Research Reports
    • Companies by Analyst
      • Biotech - David Bautz, PhD
      • Biotech - John Vandermosten, CFA
      • Bank & Finance – Ann Heffron, CFA, CPA
      • Special Situations – Ian Gilson, PhD, CFA
      • Special Situations – Steven Ralston, CFA
      • Med-Tech – Brian Marckx, CFA
      • Med-Tech - Anita Dushyanth, PhD
      • Technology – Lisa Thompson
      • Technology - M. Marin
      • Healthcare - Beth Senko, CFA
    • Companies by Name
  • Distribution
    • Institutional Distribution
    • Retail Distribution
    • Social Media
    • RSS Feeds
  • Our Partners
    • IR Firms
  • Contact
  • Subscribe
    • Zacks SCR Premium
    • Zacks SCR On-Call
Latest

Notes in the Press

August 23, 2019 MNKD: Q2 2019: Record Revenue, Margins as Rx Continue to Ramp. Clinical Evidence Driving Adoption
August 23, 2019 VVUS: Qsymia Responds to New Approach
August 23, 2019 TTNP: Long on Opportunity, Short on Capital
August 23, 2019 LPCN: NASH Trial Launched
August 23, 2019 DYAI: Another Top Tier Collaboration
August 23, 2019 MOGO: Core Revenues Grow 43% in Q2, But Discontinued Crypto Mining Challenges Sequential Improvement in Q3
August 22, 2019 SNGX: Interim Analysis for Phase 3 Oral Mucositis Trial Imminent
August 22, 2019 CTSO: Q2 19: Product Sales Rebound to Record High Despite Distributor Hangover. Value-Inflection Opportunities Abound
August 21, 2019 INMB: Positive Preliminary Phase 1 Data for INB03…
August 20, 2019 OGEN: Enrollment in Phase 2 Trial of AG013 to Complete in 4Q19…
 

Invalid login, please try again. You have retries remaining before your account will be locked.

Your account is locked and it will be unlocked automatically in minutes.

User ID:
Password:
Remember my ID:

COPYRIGHT © ZACKS INVESTMENT RESEARCH 2018
  • Disclaimer
  • Privacy Policy
  • Site Map
Tweet Follow @ZacksSmallCap
Powered By Q4 Inc. 5.23.3.1